Abstract Between January 1986 and December 1988, 36 patients with primary advanced or
recurrent cervical carcinoma were treated with cytostatic drugs in our department. Treatment …

OBJECTIVE: Use of positron emission tomography/computed tomography (PET/CT) and
serum squamous cell carcinoma (SCC) antigen (SCC-ag) as predictors for poor prognosis of …

PURPOSE.: To explore clinical/pathologic factors associated with prognosis of patients with
locally advanced cervical carcinoma treated with weekly cisplatin and pelvic radiation …

Purpose: To identify prognostic factors for local and distant relapse and perform risk
stratification for patients with advanced cervical cancer treated with radiotherapy (RT) alone …

Background Concurrent chemoradiotherapy (CCRT) is effective in the treatment of locally
advanced cervical squamous cell carcinoma (SCC). However, whether treatment outcomes …

Background This study aimed to compare the survival outcomes between squamous cell
carcinoma (SCC) and adenocarcinoma/adenosquamous carcinoma (AC/ASC) of the cervix …

Purpose: The authors conducted this retrospective study to evaluate the efficacy of
radiotherapy (RT) for high-risk patients with adenocarcinoma (AC) compared with …

Optimal cutoff level of serum squamous cell carcinoma antigen to detect recurrent cervical
squamous cell carcinoma during post-t Page 1 www.ogscience.org 337 Original Article Obstet …

Objective. The aim of this study was to determine the potential clinical utility of tumor markers
carcinoembryonic antigen (CEA), tissue polypeptide antigen (TPA), and squamous cell …

Background Neoadjuvant chemotherapy (NAC) is not yet widely recommended for the
treatment of stage I/II cervical cancer. However, it may be possible to achieve a favorable …